Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study
Robyn H. Guymer(The Royal Victorian Eye & Ear Hospital), Glenn J. Jaffe(Duke University), Michael S. Ip(Union Hospital), James G. Fujimoto(IIT@MIT), Tavé van Zyl(Regeneron (United States)), Marlene Saßmannshausen(University Hospital Bonn), David N. Zacks(University of Michigan), Zhichao Wu(Centre for Eye Research Australia), Justis P. Ehlers(Cleveland Clinic), Philip J. Rosenfeld(University of Miami), Hao Chen(Zhejiang University), Jie Shen(Xinjiang Medical University), Frederick L. Ferris(National Institutes of Health), Mayssa Attar(AbbVie (United States)), Maximilian Pfau(University of Basel)
Cited by 5
Related Papers
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
|JAMA|2017|3.3k
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
|Ophthalmology|2012|1.7k
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
|Nature Genetics|2015|1.6k
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802